Gryphon closes sale of HEPACO to Clean Harbors

Following the deal's closing, Clean Harbors expects Hepaco will add about $30 million of adjusted EBITDA to its 2024 earnings outlook. 

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this